MedTrace Logo

Hemodynamic Optimization During Major Urological Surgery

NCT03474224 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-06-07

No results posted yet for this study

Summary

In this prospective observational study investigators aim to seek for any possible correlation between the venous to arterial carbon dioxide difference (pCO2 gap) at the end of surgery and the percentage of time spent above a predefined threshold of stroke volume (SV) andn mean arterial pressure (MAP).

Conditions

  • Hemodynamic Instability

Interventions

DEVICE

Ev1000 Clinical Platform from Edwards Lifesciences

The EV1000 Hemodynamic monitoring platform will be used to guide fluid administration following a volume-based parameter such the stroke volume.

Sponsors & Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • Andrea Russo, MD · Department of Anesthesiology

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-05
Primary Completion
2020-07-21
Completion
2020-07-28
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03474224 on ClinicalTrials.gov